这是一篇来自已证抗体库的有关人类 podoplanin的综述,是根据49篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合podoplanin 抗体。
podoplanin 同义词: AGGRUS; GP36; GP40; Gp38; HT1A-1; OTS8; PA2.26; T1A; T1A-2; T1A2; TI1A

BioLegend
小鼠 单克隆(D2-40)
  • 免疫细胞化学; 人类; 1:40; 图 1
BioLegend podoplanin抗体(BioLegend, D2-40)被用于被用于免疫细胞化学在人类样本上浓度为1:40 (图 1). Biomed Res Int (2019) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类; 图 2d
BioLegend podoplanin抗体(BioLegend, 337011)被用于被用于流式细胞仪在人类样本上 (图 2d). Cell (2018) ncbi
大鼠 单克隆(NC-08)
  • 免疫组化-石蜡切片; 人类
  • 流式细胞仪; 人类; 图 1a
BioLegend podoplanin抗体(Biolegend, NC-08)被用于被用于免疫组化-石蜡切片在人类样本上 和 被用于流式细胞仪在人类样本上 (图 1a). PLoS Biol (2017) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 3
BioLegend podoplanin抗体(Covance, SIG-3730)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 3). Oncotarget (2016) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类; 图 4
BioLegend podoplanin抗体(BioLegend, 337003)被用于被用于流式细胞仪在人类样本上 (图 4). Arthritis Res Ther (2016) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类; 图 1b
BioLegend podoplanin抗体(Biolegend, NC-08)被用于被用于流式细胞仪在人类样本上 (图 1b). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类
BioLegend podoplanin抗体(Biolegend, NC-08)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类; 图 st1
BioLegend podoplanin抗体(BioLegen d, 337004)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
大鼠 单克隆(NC-08)
  • 流式细胞仪; 人类; 1:200; 图 2
BioLegend podoplanin抗体(BioLegend, 337006)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2). J Vis Exp (2015) ncbi
大鼠 单克隆(NC-08)
  • 免疫组化-冰冻切片; 人类; 图 4a
BioLegend podoplanin抗体(BioLegend, 337004)被用于被用于免疫组化-冰冻切片在人类样本上 (图 4a). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:25
BioLegend podoplanin抗体(Signet Laboratories, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:25. Exp Hematol Oncol (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:25
BioLegend podoplanin抗体(Signet Laboratories, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:25. Hum Pathol (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫细胞化学; 人类; 1:500
BioLegend podoplanin抗体(Covance, SIG-3730)被用于被用于免疫细胞化学在人类样本上浓度为1:500. PLoS ONE (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类
  • 免疫印迹; 人类
BioLegend podoplanin抗体(Covance, SIG-3730)被用于被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上. J Neuroinflammation (2013) ncbi
赛默飞世尔
大鼠 单克隆(NZ-1.3)
  • 免疫组化-冰冻切片; 人类; 图 1e
赛默飞世尔 podoplanin抗体(eBioscience, NZ-1.3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1e). Nature (2019) ncbi
大鼠 单克隆(NZ-1.3)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4b
赛默飞世尔 podoplanin抗体(ebioscience, 12-9381-42)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4b). PLoS ONE (2017) ncbi
大鼠 单克隆(NZ-1.3)
  • 免疫组化-冰冻切片; 人类; 图 1a
  • 流式细胞仪; 人类; 图 4a
  • 免疫细胞化学; 人类; 图 2
赛默飞世尔 podoplanin抗体(eBioscience, NZ 3.1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1a), 被用于流式细胞仪在人类样本上 (图 4a) 和 被用于免疫细胞化学在人类样本上 (图 2). Arthritis Res Ther (2016) ncbi
大鼠 单克隆(NZ-1.3)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 podoplanin抗体(eBioscience, NZ-1.3)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:400; 表 4
赛默飞世尔 podoplanin抗体(Thermo, D2-40)被用于被用于免疫组化在人类样本上浓度为1:400 (表 4). Diagn Pathol (2016) ncbi
大鼠 单克隆(NZ-1.3)
  • 免疫组化; 人类; 图 2k
赛默飞世尔 podoplanin抗体(eBioscience, NZ-1.3)被用于被用于免疫组化在人类样本上 (图 2k). Exp Dermatol (2015) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 podoplanin抗体(Thermo Scientific, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔 podoplanin抗体(Zymed, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Virchows Arch (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(18H5)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 3a
艾博抗(上海)贸易有限公司 podoplanin抗体(Abcam, ab10288)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 3a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(18H5)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1b
艾博抗(上海)贸易有限公司 podoplanin抗体(Abcam, ab10288)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1b). Arthritis Res Ther (2017) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:100; 图 1a
艾博抗(上海)贸易有限公司 podoplanin抗体(Abcam, ab77854)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1a). PLoS ONE (2017) ncbi
小鼠 单克隆(18H5)
  • 免疫组化; 人类; 1:100; 图 1
艾博抗(上海)贸易有限公司 podoplanin抗体(Abcam, ab10288)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1). Breast Cancer Res Treat (2015) ncbi
小鼠 单克隆(18H5)
  • 免疫细胞化学; 人类
艾博抗(上海)贸易有限公司 podoplanin抗体(Abcam, ab10288)被用于被用于免疫细胞化学在人类样本上. Biomaterials (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(E-1)
  • 免疫细胞化学; 人类; 1:50; 图 7c
圣克鲁斯生物技术 podoplanin抗体(Santa Cruz, sc-376695)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 7c). Cancer Res (2018) ncbi
小鼠 单克隆(18H5)
  • 流式细胞仪; 人类; 1:100; 图 3
  • 免疫细胞化学; 人类; 1:50; 图 3
圣克鲁斯生物技术 podoplanin抗体(Santa Cruz, sc-59347)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 3) 和 被用于免疫细胞化学在人类样本上浓度为1:50 (图 3). Cell Death Differ (2016) ncbi
小鼠 单克隆(18H5)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
圣克鲁斯生物技术 podoplanin抗体(Santa Cruz, 18H5)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Med Mol Morphol (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(D2-40)
  • 流式细胞仪; 人类; 图 2a
  • 免疫组化; 人类; 图 1a
伯乐(Bio-Rad)公司 podoplanin抗体(Serotec, MCA2543)被用于被用于流式细胞仪在人类样本上 (图 2a) 和 被用于免疫组化在人类样本上 (图 1a). Sci Rep (2017) ncbi
安迪生物R&D
家羊 多克隆
  • 免疫细胞化学; 人类; 图 1
安迪生物R&D podoplanin抗体(R&D systems, BAF3670)被用于被用于免疫细胞化学在人类样本上 (图 1). Mol Med Rep (2016) ncbi
家羊 多克隆
  • 流式细胞仪; 人类; 1:20; 图 1
安迪生物R&D podoplanin抗体(R&D systems, FAB3670A)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1). Mol Med Rep (2016) ncbi
LifeSpan Biosciences
Syrian golden hamster 单克隆(8.1.1)
  • 免疫组化-石蜡切片; 小鼠; 1:2000; 图 1c
LifeSpan Biosciences podoplanin抗体(LifeSpan Biosciences, LS-C143022)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:2000 (图 1c). Stem Cell Reports (2016) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 4g
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, M3619)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 4g). Nat Protoc (2017) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Am J Dermatopathol (2017) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 图 2b
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2b). Am J Pathol (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 表 2
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上 (表 2). Histopathology (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 图 2a
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, M3619)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2a). Dis Markers (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:200; 表 2
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (表 2). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:50; 图 1
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化在人类样本上浓度为1:50 (图 1). Diabetes (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫印迹; 人类; 图 3d
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(DAKO, D2-40)被用于被用于免疫印迹在人类样本上 (图 3d). Tumour Biol (2016) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类; 1:200; 表 3
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(DAKO, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (表 3). Clinics (Sao Paulo) (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:100
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化在人类样本上浓度为1:100. J Cutan Pathol (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化在人类样本上. Am J Dermatopathol (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:25
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化在人类样本上浓度为1:25. BMC Clin Pathol (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 人类; 1:100
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(DAKO, M3619)被用于被用于免疫组化在人类样本上浓度为1:100. Virchows Arch (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(DakoCytomation, M3619)被用于被用于免疫组化-石蜡切片在人类样本上. Transl Res (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化; 大鼠; 1:100
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, M3619)被用于被用于免疫组化在大鼠样本上浓度为1:100. Mol Hum Reprod (2014) ncbi
小鼠 单克隆(D2-40)
  • 免疫组化-石蜡切片; 人类
丹科医疗器械技术服务(上海)有限公司 podoplanin抗体(Dako, D2-40)被用于被用于免疫组化-石蜡切片在人类样本上. Oncotarget (2014) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D9D7)
  • 免疫组化-石蜡切片; 人类; 1:600; 图 1b
  • 免疫印迹; 人类; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司 podoplanin抗体(Cell Signaling, 9047)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:600 (图 1b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 4b). Mol Med Rep (2017) ncbi
MBL International
单克隆
  • 免疫组化; 人类
MBL International podoplanin抗体(MBL, D189-1)被用于被用于免疫组化在人类样本上. Respir Res (2014) ncbi
文章列表
  1. Hsu Y, Huang C, Lin K, Kuo Y, Lan M, Lan M. Podoplanin, a Potential Therapeutic Target for Nasopharyngeal Carcinoma. Biomed Res Int. 2019;2019:7457013 pubmed 出版商
  2. Croft A, Campos J, Jansen K, Turner J, Marshall J, Attar M, et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature. 2019;570:246-251 pubmed 出版商
  3. Bergqvist F, Carr A, Wheway K, Watkins B, Oppermann U, Jakobsson P, et al. Divergent roles of prostacyclin and PGE2 in human tendinopathy. Arthritis Res Ther. 2019;21:74 pubmed 出版商
  4. Kinchen J, Chen H, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;175:372-386.e17 pubmed 出版商
  5. Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y, et al. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition. Cancer Res. 2018;78:230-245 pubmed 出版商
  6. Li J, Chen H, Li X, Wang L, Gao A, Zhang P, et al. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma. Mol Med Rep. 2017;16:1643-1652 pubmed 出版商
  7. Gibot L, Galbraith T, Bourland J, Rogic A, Skobe M, Auger F. Tissue-engineered 3D human lymphatic microvascular network for in vitro studies of lymphangiogenesis. Nat Protoc. 2017;12:1077-1088 pubmed 出版商
  8. Weeden C, Chen Y, Ma S, Hu Y, Ramm G, Sutherland K, et al. Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway. PLoS Biol. 2017;15:e2000731 pubmed 出版商
  9. Dakin S, Buckley C, Al Mossawi M, Hedley R, Martinez F, Wheway K, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19:16 pubmed 出版商
  10. He N, van Iperen L, de Jong D, Szuhai K, Helmerhorst F, van der Westerlaken L, et al. Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics before Remodeling Spiral Arteries during Early Pregnancy. PLoS ONE. 2017;12:e0169849 pubmed 出版商
  11. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  12. Cullen D, Diaz Recuero J, Cullen R, Rodriguez Peralto J, Kutzner H, Requena L. Superficial Acral Fibromyxoma: Report of 13 Cases With New Immunohistochemical Findings. Am J Dermatopathol. 2017;39:14-22 pubmed 出版商
  13. Croft A, Naylor A, Marshall J, Hardie D, Zimmermann B, Turner J, et al. Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther. 2016;18:270 pubmed
  14. Ray S, Chiba N, Yao C, Guan X, McConnell A, Brockway B, et al. Rare SOX2+ Airway Progenitor Cells Generate KRT5+ Cells that Repopulate Damaged Alveolar Parenchyma following Influenza Virus Infection. Stem Cell Reports. 2016;7:817-825 pubmed 出版商
  15. Gujam F, McMillan D, Edwards J. The relationship between total and phosphorylated STAT1 and STAT3 tumour cell expression, components of tumour microenvironment and survival in patients with invasive ductal breast cancer. Oncotarget. 2016;7:77607-77621 pubmed 出版商
  16. Nazari B, Rice L, Stifano G, Barron A, Wang Y, Korndorf T, et al. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Am J Pathol. 2016;186:2650-64 pubmed 出版商
  17. Harfuddin Z, Dharmadhikari B, Wong S, Duan K, Poidinger M, Kwajah S, et al. Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. Sci Rep. 2016;6:29712 pubmed 出版商
  18. Peckova K, Michal M, Hadravsky L, Suster S, Damjanov I, Miesbauerova M, et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69:762-774 pubmed 出版商
  19. Belfort Mattos P, Focchi G, Ribalta J, Megale De Lima T, Nogueira Carvalho C, Kesselring Tso F, et al. Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions. Dis Markers. 2016;2016:8293196 pubmed 出版商
  20. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed 出版商
  21. Pethő Z, Tanner M, Tajhya R, Huq R, Laragione T, Panyi G, et al. Different expression of ? subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes. Arthritis Res Ther. 2016;18:103 pubmed 出版商
  22. Lee J, Han A, Lee S, Min W, Kim H. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment. Mol Med Rep. 2016;13:3849-57 pubmed 出版商
  23. Ando K, Fujino N, Mitani K, Ota C, Okada Y, Kondo T, et al. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol. 2016;310:L899-908 pubmed 出版商
  24. Cordeiro O, Chypre M, Brouard N, Rauber S, Alloush F, Romera Hernandez M, et al. Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL. PLoS ONE. 2016;11:e0151848 pubmed 出版商
  25. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  26. Chernova T, Sun X, Powley I, Galavotti S, Grosso S, Murphy F, et al. Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease. Cell Death Differ. 2016;23:1152-64 pubmed 出版商
  27. Korsgren E, Korsgren O. An Apparent Deficiency of Lymphatic Capillaries in the Islets of Langerhans in the Human Pancreas. Diabetes. 2016;65:1004-8 pubmed 出版商
  28. Zhang X, Jung I, Hwang Y. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2016;37:2555-63 pubmed 出版商
  29. Tajima S, Takashi Y, Ito N, Fukumoto S, Fukuyama M. ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. Med Mol Morphol. 2016;49:203-209 pubmed
  30. Lokmic Z, Ng E, Burton M, Stanley E, Penington A, Elefanty A. Isolation of human lymphatic endothelial cells by multi-parameter fluorescence-activated cell sorting. J Vis Exp. 2015;:e52691 pubmed 出版商
  31. Brunner P, Glitzner E, Reininger B, Klein I, Stary G, Mildner M, et al. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin. Exp Dermatol. 2015;24:522-8 pubmed 出版商
  32. Park S, Kim H, Koo J. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat. 2015;149:727-41 pubmed 出版商
  33. Christianson D, Dobroff A, Proneth B, Zurita A, Salameh A, Dondossola E, et al. Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis. Proc Natl Acad Sci U S A. 2015;112:2521-6 pubmed 出版商
  34. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed 出版商
  35. Almeida B, Bacchi C, Carvalho J, Ferreira C, Carvalho F. The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors. Clinics (Sao Paulo). 2014;69:660-5 pubmed 出版商
  36. Wang L, Gao T, Wang G. Verrucous hemangioma: a clinicopathological and immunohistochemical analysis of 74 cases. J Cutan Pathol. 2014;41:823-30 pubmed 出版商
  37. Trindade F, Torrelo A, Kutzner H, Requena L, Tellechea Ã, Colmenero I. An immunohistochemical study of angiokeratomas of children. Am J Dermatopathol. 2014;36:796-9 pubmed 出版商
  38. Wirsing A, Rikardsen O, Steigen S, Uhlin Hansen L, Hadler Olsen E. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin Pathol. 2014;14:38 pubmed 出版商
  39. Mosbech C, Svingen T, Nielsen J, Toft B, Rechnitzer C, Petersen B, et al. Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours. Virchows Arch. 2014;465:567-77 pubmed 出版商
  40. Miyata Y, Kanda S, Mitsunari K, Asai A, Sakai H. Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity. Transl Res. 2014;164:468-76 pubmed 出版商
  41. Abdelzaher E, Abdallah D. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int. 2014;2014:968794 pubmed 出版商
  42. Zhang L, Frank R, Furth E, Ziober A, LiVolsi V, Zhang P. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol. 2014;3:12 pubmed 出版商
  43. Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40 pubmed 出版商
  44. Svingen T, Jørgensen A, Rajpert De Meyts E. Validation of endogenous normalizing genes for expression analyses in adult human testis and germ cell neoplasms. Mol Hum Reprod. 2014;20:709-18 pubmed 出版商
  45. Suarez Carmona M, Hubert P, Gonzalez A, Duray A, Roncarati P, Erpicum C, et al. ?Np63 isoform-mediated ?-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget. 2014;5:1856-68 pubmed
  46. Jamal S, Cheriyan V, Muthu M, Munie S, Levi E, Ashour A, et al. CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. PLoS ONE. 2014;9:e89146 pubmed 出版商
  47. Luo W, Yao K. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch. 2014;464:35-43 pubmed 出版商
  48. Ghaedi M, Mendez J, Bove P, Sivarapatna A, Raredon M, Niklason L. Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. Biomaterials. 2014;35:699-710 pubmed 出版商
  49. Chaitanya G, Omura S, Sato F, Martinez N, Minagar A, Ramanathan M, et al. Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature. J Neuroinflammation. 2013;10:125 pubmed 出版商